Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry.
作者信息
Silverberg Jonathan I, Cronin Angel, Jones Eric A, Dave Swapna S, McLean Robert R, Greenberg Jeffrey, Strober Bruce, Bieber Thomas, Gooderham Melinda, Paller Amy S, Simpson Eric L
机构信息
Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
CorEvitas, LLC, Waltham, Massachusetts.
出版信息
JAAD Int. 2024 Feb 12;15:127-130. doi: 10.1016/j.jdin.2023.11.015. eCollection 2024 Jun.
Abstract
摘要
相似文献
1
Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry.在一个大型真实世界特应性皮炎患者队列中对疾病负担、治疗及合并症的特征描述：CorEvitas特应性皮炎注册研究
JAAD Int. 2024 Feb 12;15:127-130. doi: 10.1016/j.jdin.2023.11.015. eCollection 2024 Jun.
2
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.接受系统治疗 4-12 个月的特应性皮炎患者的疾病负担：来自 CorEvitas 特应性皮炎登记处的结果。
J Dermatolog Treat. 2023 Dec;34(1):2246601. doi: 10.1080/09546634.2023.2246601.
3
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry.美国和加拿大特应性皮炎患者社会人口学、临床及治疗特征的种族和民族差异：来自CorEvitas特应性皮炎注册中心的真实世界数据
Dermatol Ther (Heidelb). 2023 Sep;13(9):2045-2061. doi: 10.1007/s13555-023-00980-6. Epub 2023 Jul 22.
4
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort.涉及头、颈、面和手的特应性皮炎的患病率和负担：来自 TARGET-DERM AD 队列的横断面研究。
J Am Acad Dermatol. 2023 Sep;89(3):519-528. doi: 10.1016/j.jaad.2023.04.052. Epub 2023 May 5.
5
Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.GLOBOSTAD 长期观察性研究中的成人和青少年特应性皮炎的基线人口统计学、合并症、治疗模式和负担。
Adv Ther. 2023 Dec;40(12):5366-5382. doi: 10.1007/s12325-023-02644-5. Epub 2023 Oct 6.
6
Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry.使用系统性生物疗法的银屑病患者近乎完全清除皮肤症状的持久性：来自CorEvitas银屑病登记处的真实世界证据。
Dermatol Ther (Heidelb). 2023 Nov;13(11):2753-2768. doi: 10.1007/s13555-023-01028-5. Epub 2023 Sep 27.
7
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.美国接受特应性皮炎局部治疗患者的疾病控制不足、治疗满意度及生活质量受损情况
Dermatol Ther (Heidelb). 2021 Oct;11(5):1571-1585. doi: 10.1007/s13555-021-00580-2. Epub 2021 Jul 15.
8
Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.真实世界中特应性皮炎成年患者的治疗模式和治疗获益：来自特应性皮炎患者满意度和未满足需求调查的结果。
Acta Derm Venereol. 2022 Dec 7;102:adv00830. doi: 10.2340/actadv.v102.3932.
9
Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients.葡萄牙关于成人患者使用生物疗法和JAK抑制剂治疗特应性皮炎的建议。
Drugs Context. 2021 Dec 30;10. doi: 10.7573/dic.2021-9-5. eCollection 2021.
10
Systematic review and estimated cost-efficacy of biologics compared with narrowband ultraviolet B light for the treatment of moderate to severe psoriasis and atopic dermatitis.系统评价和生物制剂与窄谱中波紫外线治疗中重度银屑病和特应性皮炎的成本效益估计。
Int J Dermatol. 2023 Aug;62(8):986-999. doi: 10.1111/ijd.16677. Epub 2023 Apr 17.
本文引用的文献
1
How we treat atopic dermatitis now and how that will change over the next 5 years.目前我们如何治疗特应性皮炎，以及未来 5 年内将如何改变。
Br J Dermatol. 2023 May 24;188(6):718-725. doi: 10.1093/bjd/ljac116.
2
New treatments in atopic dermatitis.特应性皮炎的新疗法。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):21-31. doi: 10.1016/j.anai.2020.08.016. Epub 2020 Aug 17.
3
Treatment patterns of pediatric patients with atopic dermatitis: A claims data analysis.特应性皮炎患儿的治疗模式：一项索赔数据分析。
J Am Acad Dermatol. 2020 Mar;82(3):651-660. doi: 10.1016/j.jaad.2019.07.105. Epub 2019 Aug 7.
4
Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry.一项基于美国大型队列的疾病负担、合并症和治疗使用情况的特征分析：Corrona 银屑病登记处的研究结果。
J Am Acad Dermatol. 2018 Feb;78(2):323-332. doi: 10.1016/j.jaad.2017.10.012. Epub 2017 Oct 16.
5
Review of patient registries in dermatology.皮肤科患者登记研究综述。
J Am Acad Dermatol. 2016 Oct;75(4):824-829. doi: 10.1016/j.jaad.2016.03.020. Epub 2016 Apr 16.
Zotero 插件